Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Kidney disease drug study: no cure, just facts

NCT ID NCT06814132

First seen Nov 01, 2025 · Last updated Jun 10, 2026 · Updated 33 times

Summary

This study looked at how the drug MK-5684 moves through the bodies of men with severe kidney failure or end-stage kidney disease compared to healthy men. Twenty-four men took a single dose, and researchers measured drug levels in their blood over time. The goal was to understand kidney function's effect on the drug, not to treat any condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Orlando Clinical Research Center ( Site 0002)

    Orlando, Florida, 32809, United States

  • Research by Design ( Site 0001)

    Chicago, Illinois, 60643, United States

Conditions

The condition(s) this trial relates to.

chronic kidney disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.